NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE MKT: ELMD), today announced that, according to a preliminary list of additions posted on June 10, 2016, Electromed expects to join the Russell Microcap® Index at the conclusion of the annual reconstitution of the Index on June 24, 2016. Listing as a member, which remains in place for one year, will be effective after the U.S. market opens on June 27, 2016.
Kathleen Skarvan, Electromed’s President and Chief Executive Officer, said, "Inclusion in the Russell index is a milestone for our company and a testament to the progress we have made to deliver profitable growth. We believe our membership in this index will improve liquidity, extend our visibility within the investment community and enable us to reach additional investors and potentially broaden our shareholder base."
As a member of the Russell Microcap® Index, Electromed will be included automatically in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $6 trillion in assets are benchmarked against the Russell U.S. Indexes.
For more information on the Russell Microcap® Index and the Russell U.S. Indexes reconstitution, go to https://www.ftserussell.com/research-insights/russell-reconstitution
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota and founded in 1992. Further information about the Company can be found at www.smartvest.com.